Publications & posters

Our drug R&D is supported by scientific research published by the Akero team, our collaborators, and by external experts.

Filter

Nov 2009 | FROM EXTERNAL EXPERTS

Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models–association with liver and adipose tissue effects

Xu, J. et al. American Journal of Physiology. Endocrinology and Metabolism

Feb 2007 | FROM EXTERNAL EXPERTS

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21

Kharitonenkov, A. et al. Endocrinology

We are evaluating potential treatments for MASH and other serious metabolic diseases to build our pipeline.

View Our Pipeline

We are evaluating potential treatments for MASH and other serious metabolic diseases to build our pipeline.

View Our Pipeline